Boris Bastian, MD, PhD

Comment on "Cutaneous melanoma in childhood and adolescence shows frequent loss of INK4A and gain of KIT". (20711207)

Griewank KG, Bastian BC PMID: 20711207

Molecular analysis of a case of nevus of ota showing progressive evolution to melanoma with intermediate stages resembling cellular blue nevus. (20110797)

Gerami P, Pouryazdanparast P, Vemula S, Bastian BC PMID: 20110797

Mutation-driven drug development in melanoma. (20401974)

Flaherty KT, Hodi FS, Bastian BC PMID: 20401974

Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma. (20087158)

Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, Bastian BC PMID: 20087158

KIT as a therapeutic target in melanoma. (19847190)

Garrido MC, Bastian BC PMID: 19847190

Melanoma from bench to bedside: meeting report from the 6th international melanoma congress. (20025711)

Fisher DE, Barnhill R, Hodi FS, Herlyn M, Merlino G, Medrano E, Bastian B, Landi MT, Landi TM, Sosman J PMID: 20025711

Somatic mutation of epidermal growth factor receptor in a small subset of cutaneous squamous cell carcinoma. (19812598)

Ridd K, Bastian BC PMID: 19812598

Genome-wide associations studies for melanoma and nevi. (19686382)

Yeh I, Bastian BC PMID: 19686382

Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients. (19671862)

Harradine KA, Ridd K, Saunier EF, Clermont FF, Perez-Losada J, Moore DH, Epstein EH, Bastian BC, Akhurst RJ PMID: 19671862

Oncogenic GNAQ mutations are not correlated with disease-free survival in uveal melanoma. (19654573)

Bauer J, Kilic E, Vaarwater J, Bastian BC, Garbe C, de Klein A PMID: 19654573